Bharat Biotech to make 900 million Covaxin vaccines

500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.Sohini Das reports. IMAGE: Union Health Minister Harsh Vardhan shows......

Covaxin output scaled up to 500 million jabs a year: Bharat Biotech

This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is......

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech is targeting one billion doses in annual production. This is from its own sites alone, reports Sohini Das. India’s first indigenous Covid-19 vaccine to be approved, Bharat......

100 million Covaxin vaccines by Sept

The production of Covaxin will increase from the current 10 million doses per month to 60 million-70 million by July-August.Sohini Das reports. IMAGE: People wait to get a shot of the COVID-19......

Bharat Biotech starts Covaxin's at-risk manufacture

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results, reports Sohini Das. Photograph: Kind courtesy Bharat Biotech  ......

Covid vaccine: Pharma firms ready expansion plans

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred......

Covid-19 impact: Low interest loans likely for vaccine companies

While there has been no commitment from the government on the procurement of vaccines, initial volumes, or distribution plans, there is a likelihood that the low interest loans may be made......

Serum Institute's race to produce COVID-19 vaccine

'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'Ritwik Sharma reports. IMAGE: A quality control test conducted at the Serum......